Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bug

Showing results (151-160 of 319) with videos related to

Pageof 32
Sort By:
Clinical Epigenetics|June 19, 2012
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acidAndrea Kuendgen, Gesine Bug, Oliver G Ottmann, et al.
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cellsAnnette Romanski, Kerstin Schwarz, Maren Keller, et al.
Molecular Oncology|August 30, 2014
Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1Monika Raab, Andrea Krämer, Stephanie Hehlgans, et al.
Journal of Translational Medicine|August 13, 2017
Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMCSoo-Zin Kim-Wanner, Gesine Bug, Juliane Steinmann, et al.
Bone Marrow Transplantation|April 21, 2022
Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19Christian Niederwieser, Bodo Weber, Mirjam Reichard, et al.
Cytotherapy|October 7, 2011
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cellsEva Rettinger, Selim Kuçi, Ivonne Naumann, et al.
Leukemia|March 23, 2013
Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantationT Schroeder, J Fröbel, R-P Cadeddu, et al.
Cancer Genetics and Cytogenetics|June 2, 2009
Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtapositionStefanie Bug, Jan Dürig, Florian Oyen, et al.
BMC Pharmacology & Toxicology|September 30, 2020
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemiaFabian Lang, Lydia Wunderle, Susanne Badura, et al.
Vox Sanguinis|April 29, 2020
Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcomeOlivier Ballo, Philine Fleckenstein, Fagr Eladly, et al.
Pageof 32

Showing results (151-160 of 319) with videos related to

Sort By:
Pageof 32
Clinical Epigenetics|June 19, 2012
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acidAndrea Kuendgen, Gesine Bug, Oliver G Ottmann, et al.
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cellsAnnette Romanski, Kerstin Schwarz, Maren Keller, et al.
Molecular Oncology|August 30, 2014
Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1Monika Raab, Andrea Krämer, Stephanie Hehlgans, et al.
Journal of Translational Medicine|August 13, 2017
Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMCSoo-Zin Kim-Wanner, Gesine Bug, Juliane Steinmann, et al.
Bone Marrow Transplantation|April 21, 2022
Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19Christian Niederwieser, Bodo Weber, Mirjam Reichard, et al.
Cytotherapy|October 7, 2011
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cellsEva Rettinger, Selim Kuçi, Ivonne Naumann, et al.
Leukemia|March 23, 2013
Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantationT Schroeder, J Fröbel, R-P Cadeddu, et al.
Cancer Genetics and Cytogenetics|June 2, 2009
Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtapositionStefanie Bug, Jan Dürig, Florian Oyen, et al.
BMC Pharmacology & Toxicology|September 30, 2020
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemiaFabian Lang, Lydia Wunderle, Susanne Badura, et al.
Vox Sanguinis|April 29, 2020
Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcomeOlivier Ballo, Philine Fleckenstein, Fagr Eladly, et al.
Pageof 32